Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Mandatory HIV screening, migration and HIV stigma in Canada: exploring the experiences of sub-Saharan African immigrants living with HIV in western Canada.

Dela Cruz A, Patten S, Abdulmalik I, Harrowing J, Hall M, Afzal AR, Demeke Abate T, Carter A, Spies P, Mapfumo S, Caine V.

Health Promot Chronic Dis Prev Can. 2020 Feb;40(2):38-46. doi: 10.24095/hpcdp.40.2.02. English, French.

2.

Synthetic single domain antibodies for the conformational trapping of membrane proteins.

Zimmermann I, Egloff P, Hutter CA, Arnold FM, Stohler P, Bocquet N, Hug MN, Huber S, Siegrist M, Hetemann L, Gera J, Gmür S, Spies P, Gygax D, Geertsma ER, Dawson RJ, Seeger MA.

Elife. 2018 May 24;7. pii: e34317. doi: 10.7554/eLife.34317.

3.

Retained Bullet in the Kidney: Imaging and Conservative Management.

Mantica G, Kruger S, Ackermann H, Spies PV, Cassim F, Keyser Z, Terrone C, van der Merwe A.

Urology. 2018 Mar;113:e3-e4. doi: 10.1016/j.urology.2017.11.044. Epub 2017 Dec 7.

PMID:
29225120
4.

Penile allotransplantation for penis amputation following ritual circumcision: a case report with 24 months of follow-up.

van der Merwe A, Graewe F, Zühlke A, Barsdorf NW, Zarrabi AD, Viljoen JT, Ackermann H, Spies PV, Opondo D, Al-Qaoud T, Bezuidenhout K, Nel JD, Bailey B, Moosa MR.

Lancet. 2017 Sep 9;390(10099):1038-1047. doi: 10.1016/S0140-6736(17)31807-X. Epub 2017 Aug 17.

PMID:
28823494
5.

Self-Powered Multiparameter Health Sensor.

Tobola A, Leutheuser H, Pollak M, Spies P, Hofmann C, Weigand C, Eskofier BM, Fischer G.

IEEE J Biomed Health Inform. 2018 Jan;22(1):15-22. doi: 10.1109/JBHI.2017.2708041. Epub 2017 May 25.

PMID:
28574370
6.

The Comparative Risk of Delirium with Different Opioids: A Systematic Review.

Swart LM, van der Zanden V, Spies PE, de Rooij SE, van Munster BC.

Drugs Aging. 2017 Jun;34(6):437-443. doi: 10.1007/s40266-017-0455-9. Review.

7.

Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?

Spies PE, Pot JLWH, Willems RPJ, Bos JM, Kramers C.

Eur J Hosp Pharm. 2017 Mar;24(2):124-127. doi: 10.1136/ejhpharm-2015-000838. Epub 2016 Mar 23.

8.

The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity.

Kempf A, Tews B, Arzt ME, Weinmann O, Obermair FJ, Pernet V, Zagrebelsky M, Delekate A, Iobbi C, Zemmar A, Ristic Z, Gullo M, Spies P, Dodd D, Gygax D, Korte M, Schwab ME.

PLoS Biol. 2014 Jan;12(1):e1001763. doi: 10.1371/journal.pbio.1001763. Epub 2014 Jan 14. Erratum in: PLoS Biol. 2014 Feb;12(2):e1001818.

9.

Alzheimer biomarkers and clinical Alzheimer disease were not associated with increased cerebrovascular disease in a memory clinic population.

Spies PE, Verbeek MM, Sjogren MJ, de Leeuw FE, Claassen JA.

Curr Alzheimer Res. 2014 Jan;11(1):40-6.

PMID:
24251395
10.

Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.

Herbert MK, Aerts MB, Kuiperij HB, Claassen JAHR, Spies PE, Esselink RAJ, Bloem BR, Verbeek MM.

Alzheimers Dement. 2014 Jul;10(4):448-455.e2. doi: 10.1016/j.jalz.2013.05.1775. Epub 2013 Nov 13.

PMID:
24239248
11.

A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkers.

Spies PE, Claassen JA, Peer PG, Blankenstein MA, Teunissen CE, Scheltens P, van der Flier WM, Olde Rikkert MG, Verbeek MM.

Alzheimers Dement. 2013 May;9(3):262-8. doi: 10.1016/j.jalz.2012.01.010. Epub 2012 Nov 2.

PMID:
23123231
12.

Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer disease.

Spies PE, Verbeek MM, van Groen T, Claassen JA.

Front Biosci (Landmark Ed). 2012 Jun 1;17:2024-34. Review.

PMID:
22652762
13.

Elderly: a term to avoid or to embrace?

Spies PE, Claassen JA.

J Am Geriatr Soc. 2011 Oct;59(10):1986-7. doi: 10.1111/j.1532-5415.2011.03610_17.x. No abstract available.

PMID:
22091525
14.

CSF α-synuclein concentrations do not fluctuate over hours and are not correlated to amyloid β in humans.

Spies PE, Slats D, Rikkert MG, Tseng J, Claassen JA, Verbeek MM.

Neurosci Lett. 2011 Oct 31;504(3):336-8. doi: 10.1016/j.neulet.2011.09.063. Epub 2011 Oct 4.

PMID:
22001363
15.

AFP measurement in monitoring treatment response of advanced hepatocellular carcinoma to sorafenib: case report and review of the literature.

Gamstätter T, Weinmann A, Schadmand-Fischer S, Spies PR, Niederle IM, Schuchmann M, Galle PR, Wörns MA.

Onkologie. 2011;34(10):538-42. doi: 10.1159/000332137. Epub 2011 Sep 16.

PMID:
21985853
16.

Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers.

Slats D, Claassen JA, Spies PE, Borm G, Besse KT, van Aalst W, Tseng J, Sjögren MJ, Olde Rikkert MG, Verbeek MM.

Neurobiol Aging. 2012 Apr;33(4):831.e1-9. doi: 10.1016/j.neurobiolaging.2011.07.008. Epub 2011 Aug 31.

17.

Experiences with cerebrospinal fluid analysis in Dutch memory clinics.

Spies PE, Slats D, Ramakers I, Verhey FR, Olde Rikkert MG.

Eur J Neurol. 2011 Jul;18(7):1014-6. doi: 10.1111/j.1468-1331.2010.03222.x. Epub 2010 Sep 16.

PMID:
21658162
18.

Cerebrospinal fluid biomarkers in Alzheimer's disease: are the hypotheses more dynamic than the biomarkers?

Spies PE, Verbeek MM, Olde Rikkert MG, Claassen JA.

J Am Geriatr Soc. 2010 Aug;58(8):1619-20. doi: 10.1111/j.1532-5415.2010.03001.x. No abstract available.

PMID:
20942893
19.

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports.

Slats D, Spies PE, Sjögren MJ, Verhey FR, Verbeek MM, Olde Rikkert MG.

Case Rep Neurol. 2010 Feb 24;2(1):5-11.

20.

The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.

Spies PE, Slats D, Sjögren JM, Kremer BP, Verhey FR, Rikkert MG, Verbeek MM.

Curr Alzheimer Res. 2010 Aug;7(5):470-6.

PMID:
20043812
21.

CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer's Disease Consortium (EADC).

Slats D, Spies PE, Sjögren MJ, Visser PJ, Verbeek MM, Rikkert MG, Kehoe PG.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):124-5. doi: 10.1136/jnnp.2009.176412. No abstract available.

PMID:
20019235
22.

A simple approach to improve the sensitivity of enzyme-linked immunosorbent assay: using the IMAPlate 5RC96 for result readout.

Spies P, Mueller R, Chen GJ, Gygax D.

Anal Biochem. 2010 Feb 1;397(1):48-52. doi: 10.1016/j.ab.2009.09.032. Epub 2009 Sep 22.

PMID:
19778520
23.

Metal-free dihydrogen activation chemistry: structural and dynamic features of intramolecular P/B pairs.

Spies P, Kehr G, Bergander K, Wibbeling B, Fröhlich R, Erker G.

Dalton Trans. 2009 Mar 7;(9):1534-41. doi: 10.1039/b815832k. Epub 2009 Jan 20.

PMID:
19421595
24.

Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders.

Spies PE, Melis RJ, Sjögren MJ, Rikkert MG, Verbeek MM.

J Alzheimers Dis. 2009;16(2):363-9. doi: 10.3233/JAD-2009-0955.

PMID:
19221426
25.

A global benchmark study using affinity-based biosensors.

Rich RL, Papalia GA, Flynn PJ, Furneisen J, Quinn J, Klein JS, Katsamba PS, Waddell MB, Scott M, Thompson J, Berlier J, Corry S, Baltzinger M, Zeder-Lutz G, Schoenemann A, Clabbers A, Wieckowski S, Murphy MM, Page P, Ryan TE, Duffner J, Ganguly T, Corbin J, Gautam S, Anderluh G, Bavdek A, Reichmann D, Yadav SP, Hommema E, Pol E, Drake A, Klakamp S, Chapman T, Kernaghan D, Miller K, Schuman J, Lindquist K, Herlihy K, Murphy MB, Bohnsack R, Andrien B, Brandani P, Terwey D, Millican R, Darling RJ, Wang L, Carter Q, Dotzlaf J, Lopez-Sagaseta J, Campbell I, Torreri P, Hoos S, England P, Liu Y, Abdiche Y, Malashock D, Pinkerton A, Wong M, Lafer E, Hinck C, Thompson K, Primo CD, Joyce A, Brooks J, Torta F, Bagge Hagel AB, Krarup J, Pass J, Ferreira M, Shikov S, Mikolajczyk M, Abe Y, Barbato G, Giannetti AM, Krishnamoorthy G, Beusink B, Satpaev D, Tsang T, Fang E, Partridge J, Brohawn S, Horn J, Pritsch O, Obal G, Nilapwar S, Busby B, Gutierrez-Sanchez G, Gupta RD, Canepa S, Witte K, Nikolovska-Coleska Z, Cho YH, D'Agata R, Schlick K, Calvert R, Munoz EM, Hernaiz MJ, Bravman T, Dines M, Yang MH, Puskas A, Boni E, Li J, Wear M, Grinberg A, Baardsnes J, Dolezal O, Gainey M, Anderson H, Peng J, Lewis M, Spies P, Trinh Q, Bibikov S, Raymond J, Yousef M, Chandrasekaran V, Feng Y, Emerick A, Mundodo S, Guimaraes R, McGirr K, Li YJ, Hughes H, Mantz H, Skrabana R, Witmer M, Ballard J, Martin L, Skladal P, Korza G, Laird-Offringa I, Lee CS, Khadir A, Podlaski F, Neuner P, Rothacker J, Rafique A, Dankbar N, Kainz P, Gedig E, Vuyisich M, Boozer C, Ly N, Toews M, Uren A, Kalyuzhniy O, Lewis K, Chomey E, Pak BJ, Myszka DG.

Anal Biochem. 2009 Mar 15;386(2):194-216. doi: 10.1016/j.ab.2008.11.021. Epub 2008 Nov 27.

26.

Metal-free catalytic hydrogenation of enamines, imines, and conjugated phosphinoalkenylboranes.

Spies P, Schwendemann S, Lange S, Kehr G, Fröhlich R, Erker G.

Angew Chem Int Ed Engl. 2008;47(39):7543-6. doi: 10.1002/anie.200801432. No abstract available.

PMID:
18726976
27.

Establishment of a miniaturized enzyme-linked immunosorbent assay for human transferrin quantification using an intelligent multifunctional analytical plate.

Spies P, Chen GJ, Gygax D.

Anal Biochem. 2008 Nov 1;382(1):35-9. doi: 10.1016/j.ab.2008.07.006. Epub 2008 Jul 16.

PMID:
18655766
28.

Rapid intramolecular heterolytic dihydrogen activation by a four-membered heterocyclic phosphane-borane adduct.

Spies P, Erker G, Kehr G, Bergander K, Fröhlich R, Grimme S, Stephan DW.

Chem Commun (Camb). 2007 Dec 21;(47):5072-4. Epub 2007 Oct 2.

PMID:
18049757
29.

Structural importance of secondary interactions in molecules: origin of unconventional conformations of phosphine-borane adducts.

Spies P, Fröhlich R, Kehr G, Erker G, Grimme S.

Chemistry. 2008;14(1):333-43. Erratum in: Chemistry. 2008 Jan;14(3):779.

PMID:
17896334
30.

Treatment of choledocholithiasis following Roux-en-Y hepaticojejunostomy using double-balloon endoscopy.

Spahn TW, Grosse-Thie W, Spies P, Mueller MK.

Digestion. 2007;75(1):20-1. Epub 2007 Apr 10. No abstract available.

31.

Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset.

Litherland SA, She JX, Schatz D, Fuller K, Hutson AD, Peng RH, Li Y, Grebe KM, Whittaker DS, Bahjat K, Hopkins D, Fang Q, Spies PD, North K, Wasserfall C, Cook R, Dennis MA, Crockett S, Sleasman J, Kocher J, Muir A, Silverstein J, Atkinson M, Clare-Salzler MJ.

Pediatr Diabetes. 2003 Mar;4(1):10-8.

PMID:
14655518
32.

Characterization of two cell lines, derived from two malignant fibrous histiocytomas.

Roholl PJ, Kleyne J, Van Blokland M, Spies PL, Rutgers DH, Albus-Lutter CE, Van Unnik JA.

J Pathol. 1986 Oct;150(2):103-12.

PMID:
3025391
33.

Surface immunoglobulin restriction in B-non Hodgkin's lymphomas in cell suspension and on frozen tissue sections.

Kluin PM, de Weger RA, Schuurman HJ, Peters PP, Spies PI, Bast BJ, van Unnik JA, de Gast GC.

Scand J Haematol. 1985 Oct;35(4):399-407.

PMID:
3936163

Supplemental Content

Support Center